Wałowamedsp. z o.o.

Diagnostic imaging activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-12-01
Share capital
5,000.00 PLN
Activity description

Wałowamed provides comprehensive breast disease diagnostics, including mammography, 3D tomosynthesis and examinations for patients with implants. It performs breast, lymph node and soft-tissue biopsies under ultrasound or mammography guidance and offers oncology and radiotherapy consultations.

Registered address
ul. Wałowa 11, 30-704 Kraków, Poland
Phone
Social media

Offer

  • Mammography
  • Tomosynthesis
  • Fine-needle biopsy
  • Core-needle biopsy
  • Lymph node biopsy
  • Oncology consultation

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Tag Manager
  • Meta Pixel

Public procurement

Wałowamed is the contractor in one public sector contract, worth USD 403.97k.

SubjectAmount
Conducting comprehensive breast cancer diagnostic tests – imaging, biopsies of lesions and lymph nodes, and histopathological examinations
$403,971

National Health Fund (NFZ) contracts

Wałowamed has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 46.43k. All its contracts were worth USD 173.27k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Preventive health programmesmałopolskie1USD 46.43k

Authorized Representatives

Agnieszka Wyrobek-Kaczorage 56 – Vice President of the Management Board
Jolanta Teresa Łapczyńskaage 59 – President of the Management Board

Manner of representation

To represent the company, sign documents on its behalf, submit statements concerning the company's rights and obligations, both proprietary and non-proprietary, as well as incur obligations and dispose of rights, the sole member of the management board is authorised to act independently when the management board is a one-person management board. If the management board is a multi-member management board, the joint action of two members of the management board or of a member of the management board jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
70$945.4370%
30$405.1930%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2025-12-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
VoxelS.A.
Centermedsp. z o.o.
Sublimedsp. z o.o.
Cardiomedicumsp. z o.o.
Polska Profilaktykasp. z o.o.
Centrum Medyczne Sowasp. z o.o.
Vaccinmedsp. z o.o.
Skanaisp. z o.o.
Volumedsp. z o.o.
Zakład Rentgena I Usg - Wyrobeksp. z o.o.

FAQ

Last updated: 2026-08-21